Bryn Mawr Trust Co Cuts Holdings in Amgen

Bryn Mawr Trust Co Cuts Holdings in Amgen

BRYN MAWR TRUST Co lowered its holdings in shares of Amgen by 5.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 65,766 shares of the medical research company's stock after selling 3,577 shares during the period.

from Biotech News